According to the latest 2026 market analysis, the Ice Structuring Protein (ISP) Market—also known as Antifreeze Proteins (AFP)—is moving from a niche scientific application to a mainstream solution for premium food textures and advanced cryopreservation.
The global market was valued at approximately USD 87.7 million in 2025 and is projected to reach USD 285.4 million by 2036, growing at a robust CAGR of 11.5% over the forecast period.
The market is diversifying as biotechnology allows for more cost-effective, non-animal-derived protein sources.
Fish-Derived (Type I, II, III): Currently the largest segment. Sourced from cold-water fish like winter flounder, these are highly effective for industrial-scale ice cream production.
Plant-Derived (Kaiware Daikon, Winter Wheat): The fastest-growing segment (CAGR ~13%). Driven by the "Clean Label" and vegan movements, as consumers seek non-GMO and non-animal alternatives.
Microbial/Yeast-Source: Produced through precision fermentation. This segment is gaining traction due to high scalability and sustainability compared to wild-harvesting.
Insect-Derived: Emerging as a high-potency alternative for specialized medical and laboratory research.
Food & Beverages: Dominates the market (approx. 65% share). Primarily used in ice cream to prevent "sandiness" (ice recrystallization) and in frozen dough to maintain yeast viability.
Medical & Healthcare: Critical for the cryopreservation of organs, blood, and stem cells. ISPs significantly increase the survival rate of tissues during freeze-thaw cycles.
Agriculture: Used to enhance frost tolerance in high-value crops, potentially extending growing seasons in temperate climates.
Cosmetics: A niche but high-value segment focusing on anti-aging creams and skin protection in extreme cold.
North America (Market Leader): Accounted for 38% of the global share in 2025. Driven by high R&D spending and a massive consumer market for premium, low-fat frozen desserts where ISPs are essential for texture.
Asia-Pacific (Fastest Growing): Expected to grow at a CAGR of 14.2%. Led by China and Japan, where rapid urbanization and a booming "cold chain" infrastructure are increasing demand for high-quality frozen convenience foods.
Europe: Heavily focused on the medical and pharmaceutical sectors, with stringent regulations favoring sustainable, plant-derived ISPs.
The market is characterized by a few dominant FMCG players and specialized biotech firms.
| Tier | Key Players |
| Global Leaders | Unilever (Pioneer in food-grade ISPs), Kaneka Corporation, Nichirei Corporation |
| Biotech Innovators | AquaBounty Technologies, Sirona Biochem, ProtoKinetix, Inc. |
| Specialized/Regional | A/F Protein Inc., Global Fresh Biotech, Rishon Biochem, Kodera Herb Garden |
Bargaining Power of Suppliers (Moderate-High): Extraction from rare cold-water species is difficult; however, the rise of synthetic fermentation is reducing supplier power.
Bargaining Power of Buyers (High): Large food conglomerates (Nestlé, Unilever) have significant leverage over price and quality specifications.
Threat of New Entrants (Low-Moderate): High technical barriers in protein sequencing and regulatory approvals (FDA/EFSA) prevent rapid market entry.
Threat of Substitutes (Moderate): Traditional stabilizers (guar gum, carrageenan) are cheaper but do not offer the same "mouthfeel" or cryoprotection benefits.
Competitive Rivalry (High): Intense focus on patenting specific protein sequences and reducing production costs.
Strengths: Unrivaled ability to control ice crystal size; enables low-fat/low-sugar recipes without sacrificing texture.
Weaknesses: High production costs; complex regulatory landscape for GMO-derived yeast sources.
Opportunities: Potential for organ transplant preservation and climate-resilient agriculture.
Threats: Public perception of "engineered" proteins; high energy costs for fermentation.
Driver: The Premiumization of Frozen Food. Consumers are moving away from "cheap" ice cream toward artisanal, functional, and high-protein versions that require ISPs to stay smooth.
Challenge: Scale and Cost. Producing high-purity ISPs in metric tons remains expensive, limiting use to "premium" or "medical" tiers.
Trend: Precision Fermentation. Using AI-designed microbes to "brew" ISPs, bypassing the need for harvesting fish or insects.
Genomic Sequencing: Identifying high-activity protein sequences in nature.
Biomanufacturing: Large-scale fermentation (yeast) or extraction (fish/plants).
Purification: High-precision filtration to ensure food or medical grade purity.
Formulation: Integrating ISPs into final products (e.g., a "masterbatch" for ice cream).
Logistics: Specialized cold-chain delivery to maintain protein stability.
For Manufacturers: Shift focus to plant-based or fermentation-derived ISPs. The 2026 consumer is increasingly wary of animal-derived additives.
For Medical Researchers: Explore ISPs for vaccine stabilization, reducing the need for ultra-cold storage ($-80°\text{C}$) in developing nations.
For Investors: Prioritize companies with strong Intellectual Property (IP) in recombinant protein technology, as these hold the keys to cost-effective scaling.
1. Market Overview of Ice Structuring Protein (ISP)
1.1 Ice Structuring Protein (ISP) Market Overview
1.1.1 Ice Structuring Protein (ISP) Product Scope
1.1.2 Market Status and Outlook
1.2 Ice Structuring Protein (ISP) Market Size by Regions:
1.3 Ice Structuring Protein (ISP) Historic Market Size by Regions
1.4 Ice Structuring Protein (ISP) Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Ice Structuring Protein (ISP) Sales Market by Type
2.1 Global Ice Structuring Protein (ISP) Historic Market Size by Type
2.2 Global Ice Structuring Protein (ISP) Forecasted Market Size by Type
2.3 Yeast Source ISP
2.4 Kaiware Daikon Source ISP
2.5 Others
3. Covid-19 Impact Ice Structuring Protein (ISP) Sales Market by Application
3.1 Global Ice Structuring Protein (ISP) Historic Market Size by Application
3.2 Global Ice Structuring Protein (ISP) Forecasted Market Size by Application
3.3 Medical
3.4 Food
3.5 Agriculture
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Ice Structuring Protein (ISP) Production Capacity Market Share by Manufacturers
4.2 Global Ice Structuring Protein (ISP) Revenue Market Share by Manufacturers
4.3 Global Ice Structuring Protein (ISP) Average Price by Manufacturers
5. Company Profiles and Key Figures in Ice Structuring Protein (ISP) Business
5.1 Unilever
5.1.1 Unilever Company Profile
5.1.2 Unilever Ice Structuring Protein (ISP) Product Specification
5.1.3 Unilever Ice Structuring Protein (ISP) Production Capacity, Revenue, Price and Gross Margin
5.2 Kaneka
5.2.1 Kaneka Company Profile
5.2.2 Kaneka Ice Structuring Protein (ISP) Product Specification
5.2.3 Kaneka Ice Structuring Protein (ISP) Production Capacity, Revenue, Price and Gross Margin
5.3 Global Fresh Biotech
5.3.1 Global Fresh Biotech Company Profile
5.3.2 Global Fresh Biotech Ice Structuring Protein (ISP) Product Specification
5.3.3 Global Fresh Biotech Ice Structuring Protein (ISP) Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Ice Structuring Protein (ISP) Market Size
6.2 North America Ice Structuring Protein (ISP) Key Players in North America
6.3 North America Ice Structuring Protein (ISP) Market Size by Type
6.4 North America Ice Structuring Protein (ISP) Market Size by Application
7. East Asia
7.1 East Asia Ice Structuring Protein (ISP) Market Size
7.2 East Asia Ice Structuring Protein (ISP) Key Players in North America
7.3 East Asia Ice Structuring Protein (ISP) Market Size by Type
7.4 East Asia Ice Structuring Protein (ISP) Market Size by Application
8. Europe
8.1 Europe Ice Structuring Protein (ISP) Market Size
8.2 Europe Ice Structuring Protein (ISP) Key Players in North America
8.3 Europe Ice Structuring Protein (ISP) Market Size by Type
8.4 Europe Ice Structuring Protein (ISP) Market Size by Application
9. South Asia
9.1 South Asia Ice Structuring Protein (ISP) Market Size
9.2 South Asia Ice Structuring Protein (ISP) Key Players in North America
9.3 South Asia Ice Structuring Protein (ISP) Market Size by Type
9.4 South Asia Ice Structuring Protein (ISP) Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Ice Structuring Protein (ISP) Market Size
10.2 Southeast Asia Ice Structuring Protein (ISP) Key Players in North America
10.3 Southeast Asia Ice Structuring Protein (ISP) Market Size by Type
10.4 Southeast Asia Ice Structuring Protein (ISP) Market Size by Application
11. Middle East
11.1 Middle East Ice Structuring Protein (ISP) Market Size
11.2 Middle East Ice Structuring Protein (ISP) Key Players in North America
11.3 Middle East Ice Structuring Protein (ISP) Market Size by Type
11.4 Middle East Ice Structuring Protein (ISP) Market Size by Application
12. Africa
12.1 Africa Ice Structuring Protein (ISP) Market Size
12.2 Africa Ice Structuring Protein (ISP) Key Players in North America
12.3 Africa Ice Structuring Protein (ISP) Market Size by Type
12.4 Africa Ice Structuring Protein (ISP) Market Size by Application
13. Oceania
13.1 Oceania Ice Structuring Protein (ISP) Market Size
13.2 Oceania Ice Structuring Protein (ISP) Key Players in North America
13.3 Oceania Ice Structuring Protein (ISP) Market Size by Type
13.4 Oceania Ice Structuring Protein (ISP) Market Size by Application
14. South America
14.1 South America Ice Structuring Protein (ISP) Market Size
14.2 South America Ice Structuring Protein (ISP) Key Players in North America
14.3 South America Ice Structuring Protein (ISP) Market Size by Type
14.4 South America Ice Structuring Protein (ISP) Market Size by Application
15. Rest of the World
15.1 Rest of the World Ice Structuring Protein (ISP) Market Size
15.2 Rest of the World Ice Structuring Protein (ISP) Key Players in North America
15.3 Rest of the World Ice Structuring Protein (ISP) Market Size by Type
15.4 Rest of the World Ice Structuring Protein (ISP) Market Size by Application
16 Ice Structuring Protein (ISP) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
The market is diversifying as biotechnology allows for more cost-effective, non-animal-derived protein sources.
Fish-Derived (Type I, II, III): Currently the largest segment. Sourced from cold-water fish like winter flounder, these are highly effective for industrial-scale ice cream production.
Plant-Derived (Kaiware Daikon, Winter Wheat): The fastest-growing segment (CAGR ~13%). Driven by the "Clean Label" and vegan movements, as consumers seek non-GMO and non-animal alternatives.
Microbial/Yeast-Source: Produced through precision fermentation. This segment is gaining traction due to high scalability and sustainability compared to wild-harvesting.
Insect-Derived: Emerging as a high-potency alternative for specialized medical and laboratory research.
Food & Beverages: Dominates the market (approx. 65% share). Primarily used in ice cream to prevent "sandiness" (ice recrystallization) and in frozen dough to maintain yeast viability.
Medical & Healthcare: Critical for the cryopreservation of organs, blood, and stem cells. ISPs significantly increase the survival rate of tissues during freeze-thaw cycles.
Agriculture: Used to enhance frost tolerance in high-value crops, potentially extending growing seasons in temperate climates.
Cosmetics: A niche but high-value segment focusing on anti-aging creams and skin protection in extreme cold.
North America (Market Leader): Accounted for 38% of the global share in 2025. Driven by high R&D spending and a massive consumer market for premium, low-fat frozen desserts where ISPs are essential for texture.
Asia-Pacific (Fastest Growing): Expected to grow at a CAGR of 14.2%. Led by China and Japan, where rapid urbanization and a booming "cold chain" infrastructure are increasing demand for high-quality frozen convenience foods.
Europe: Heavily focused on the medical and pharmaceutical sectors, with stringent regulations favoring sustainable, plant-derived ISPs.
The market is characterized by a few dominant FMCG players and specialized biotech firms.
| Tier | Key Players |
| Global Leaders | Unilever (Pioneer in food-grade ISPs), Kaneka Corporation, Nichirei Corporation |
| Biotech Innovators | AquaBounty Technologies, Sirona Biochem, ProtoKinetix, Inc. |
| Specialized/Regional | A/F Protein Inc., Global Fresh Biotech, Rishon Biochem, Kodera Herb Garden |
Upto 24 to 48 hrs (Working Hours)
Upto 72 hrs max (Working Hours) - Weekends and Public Holidays
Single User License - Allows access to only one person to the report.
Multi User License - Allows sharing with max 5 persons within organization.
Corporate License – Can be shared across entire organization.
Online Payments with PayPal
Wire Transfer / Bank Transfer
At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.
ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.
We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.
Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.
Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.